GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » PB Ratio

Shanghai Haohai Biological Technology Co (HKSE:06826) PB Ratio : 1.14 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), Shanghai Haohai Biological Technology Co's share price is HK$42.30. Shanghai Haohai Biological Technology Co's Book Value per Share for the quarter that ended in Mar. 2024 was HK$37.06. Hence, Shanghai Haohai Biological Technology Co's PB Ratio of today is 1.14.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's PB Ratio or its related term are showing as below:

HKSE:06826' s PB Ratio Range Over the Past 10 Years
Min: 0.86   Med: 1.13   Max: 1.33
Current: 1.14

During the past 10 years, Shanghai Haohai Biological Technology Co's highest PB Ratio was 1.33. The lowest was 0.86. And the median was 1.13.

HKSE:06826's PB Ratio is ranked better than
77.21% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs HKSE:06826: 1.14

During the past 3 years, the average Book Value Per Share Growth Rate was -0.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 5.60% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Haohai Biological Technology Co was 72.00% per year. The lowest was -0.50% per year. And the median was 15.60% per year.

Back to Basics: PB Ratio


Shanghai Haohai Biological Technology Co PB Ratio Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co PB Ratio Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 1.28 1.29 1.04 1.12

Shanghai Haohai Biological Technology Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.88 1.27 1.12 1.08

Competitive Comparison of Shanghai Haohai Biological Technology Co's PB Ratio

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's PB Ratio falls into.



Shanghai Haohai Biological Technology Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Shanghai Haohai Biological Technology Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=42.30/37.057
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Shanghai Haohai Biological Technology Co  (HKSE:06826) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Shanghai Haohai Biological Technology Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (HKSE:06826) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Shanghai Haohai Biological Technology Co (HKSE:06826) Headlines

No Headlines